Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease

NCT07367815 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: CellREADY® drug product IV dose of 50 millions
DRUG: CellREADY® drug product IV dose of 100 millions
DIAGNOSTIC_TEST: cerebral RMI
DIAGNOSTIC_TEST: PET scan

Sponsor

University Hospital, Toulouse